Metabolite

KNApSAcK Entry

id C00018319
Name Myxothiazol / Myxothiazole A
CAS RN 76706-55-3
Standard InChI InChI=1S/C25H33N3O3S2/c1-16(2)9-7-8-10-17(3)24-28-20(15-33-24)25-27-19(14-32-25)11-12-21(30-5)18(4)22(31-6)13-23(26)29/h7-18,21H,1-6H3,(H2,26,29)/b9-7+,10-8+,12-11+,22-13+/t17-,18+,21-/m0/s1
Standard InChI (Main Layer) InChI=1S/C25H33N3O3S2/c1-16(2)9-7-8-10-17(3)24-28-20(15-33-24)25-27-19(14-32-25)11-12-21(30-5)18(4)22(31-6)13-23(26)29/h7-18,21H,1-6H3,(H2,26,29)

Cluster

Phytochemical cluster
KCF-S cluster No. 4167

Link

ChEMBL

By standard InChI CHEMBL454568
By standard InChI Main Layer CHEMBL454568 CHEMBL605952

KEGG

By LinkDB C15674

CTD

By CAS RN C030517

Species

Summary

Plant class

class name count

Family

family name count
Myxococcaceae 1

List (1)

* NCBI
KNApSAcK organism *ID *family *plant class *kingdom
Myxococcus fulvus strain Mx f16 32 Myxococcaceae Bacteria

Human Protein / Gene in interaction

CTD interaction (5)

compound gene gene name gene description interaction interaction type form reference
pmid
C030517 948 CD36
BDPLT10
CHDS7
FAT
GP3B
GP4
GPIV
PASIV
SCARB3
CD36 molecule (thrombospondin receptor) myxothiazol inhibits the reaction [[Oxygen deficiency results in increased abundance of Reactive Oxygen Species] which results in increased expression of CD36 mRNA] decreases reaction
/ increases abundance
/ increases expression
mRNA 19640849
C030517 10725 NFAT5
NF-AT5
NFATL1
NFATZ
OREBP
TONEBP
nuclear factor of activated T-cells 5, tonicity-responsive myxothiazol inhibits the reaction [Sodium Chloride results in increased activity of NFAT5 protein] decreases reaction
/ increases activity
protein 16303854
C030517 6539 SLC6A12
BGT-1
BGT1
GAT2
solute carrier family 6 (neurotransmitter transporter), member 12 myxothiazol inhibits the reaction [Sodium Chloride results in increased expression of SLC6A12 mRNA] decreases reaction
/ increases expression
mRNA 16303854
C030517 6648 SOD2
IPOB
MNSOD
MVCD6
superoxide dismutase 2, mitochondrial (EC:1.15.1.1) myxothiazol inhibits the reaction [TNF protein results in increased expression of SOD2 mRNA] decreases reaction
/ increases expression
mRNA 11264281
C030517 7124 TNF
DIF
TNF-alpha
TNFA
TNFSF2
tumor necrosis factor myxothiazol inhibits the reaction [TNF protein results in increased expression of SOD2 mRNA] decreases reaction
/ increases expression
protein 11264281

Related Disease

Diseases related to CTD interactions

2 disease from interactions of metabolites

MeSH disease OMIM compound disease name evidence type reference
pmid
D009336 C030517 Necrosis marker/mechanism
19193189
D010190 C030517 Pancreatic Neoplasms therapeutic
17040906